While interleukin-1β (IFβ), chemokine (C-X-C motif) ligand 10 (CXCL10), and IL-8 were detected in neuroendocrine tumors (NCL H727) treated with 177Lu-DOTA-TATE, other studies have reported the presence of FasL, TRAIL, and IL-1β in in vivo models of non-Hodgkin’s lymphoma treated with 90Y-ibritumomab tiuxetan. The gene discussed is CXCL10; the disease is non-Hodgkin lymphoma.